entremed.com Pages on BioPortfolio:

BioPortfolio.com - BioWeb THALOMID THALIDOMIDE ballv. lantero ...
EntreMed, Inc. Announces Commencement of Phase I Clinical Trial Of Orally-Active ... Gubish, Jr., EntreMed's Executive Vice President for Research and ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

Biotechnology News arthritis panzem. enmd. entrem. 2076. thalomid ...
EntreMed Reports Clinical Program Progress and Company Update ... EntreMed's MKC -1 meets primary efficacy endpoint in non-small cell lung cancer clinical ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - @entremed.com
entremed.com - BioPortfolio. ... Recent Search Terms used to find this page: entremed.com | entremed.com | EntreMed Incorporated | Entremed . ...
http://www.bioportfolio.com/search/@entremed.com.html...

Biotechnology News Burns Search
EntreMed Reports Clinical Program Progress and Company Update ROCKVILLE, Md., Nov. 12, /PRNewswire-FirstCall/ -- EntreMed, Inc. ...
http://www.bioportfolio.co.uk/Burns-news.htm...

BioPortfolio - Biocorporate Search Multiple Sclerosis
EntreMed, Inc. is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells directly and the ...
http://www.bioportfolio.com/biocorporate/Multiple%20Sclerosi...

Biotechnology and Pharmaceutical Industry Search Find Companies ...
EntreMed to Present at the Rodman and Renshaw 10th Annual Healthcare Conference ... EntreMed Inc., which specializes in cancer and inflammatory disease ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Biotechnology and Pharmaceutical Industry Search Find Companies ...
EntreMed Reports Clinical Program Progress and Company Update ... EntreMed to Present at the Rodman and Renshaw 10th Annual Healthcare Conference ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Results from other life science and pharmaceutical sites:

BioSpace - EntreMed, Inc. News, Search Jobs, Events
EntreMed, Inc. is a clinical-stage pharmaceutical company focused on developing multi-mechanism drugs that target disease cells directly and the blood ...
http://www.biospace.com/company_profile.aspx?CompanyId=2078...

Elan: Elan and EntreMed Execute License Agreement for Proprietary ...
Under the License Agreement and corresponding Services Agreement, Elan will manufacture EntreMed's Panzem® NCD, a NanoCrystal Technology formulation with
...
http://www.elan.com/news/2006/20060110.asp...

EntreMed, Inc. Presents Results for ENMD-1198 and Vincristine in ...
10 /PRNewswire-FirstCall/ -- EntreMed, Inc. , a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory ...
http://www.biospace.com/news_story.aspx?NewsEntityId=80013...

EntreMed to Present at BioPartnering Europe Conference
EntreMed is actively marketing ENMD-2076 and 2ME2 for RA to prospective pharmaceutical and biotech company partners as a means to accelerate the
development ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=ind_focus....

EntreMed, Inc. Reports Clinical Program Progress and Company ...
The updates were given during a podium presentation by EntreMed President & CEO, James S. Burns, and web cast at the Rodman & Renshaw 10th Annual Healthcare ...
http://www.biospace.com/news_story.aspx?NewsEntityId=117152...

Entremed - Investor Relations: News
EntreMed's scientific team, including collaborators, will present 14 different abstracts covering three drug classes -- proteins, small molecules and ...
http://www.prnewswire.com/cgi-bin/micro_stories.pl?ACCT=no&T...

EntreMed, Inc. Presents MKC-1 Phase 2 Data at American Society of ...
Carolyn F. Sidor, MD, MBA, EntreMed Vice President and Chief Medical Officer commented on the results, "Although we did not meet our overall goal for this
...
http://www.biospace.com/news_story.aspx?NewsEntityId=98731...

EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR ...
The data will be presented by EntreMed scientists and collaborators during the American Association for Cancer Research (AACR) Annual Meeting being held ...
http://prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www...

EntreMed Reports Clinical Program Progress and Company Update ...
EntreMed Reports Clinical Program Progress and Company Update. - ROCKVILLE, Md., Nov. 12, /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD - News), ...
http://biz.yahoo.com/prnews/081112/ph45548.html?.v=1...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.